APO Research
Talk to an analyst

APO RESEARCH · REPORT

Statin

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Statin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025194 pages

Choose your research edition.

Industry ResearchStatin Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Statin Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Statin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Statin Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Statin Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Statin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Statin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Statin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Statin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Statin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Statin include CHIA TAI TIANQING, Zhejiang Jingxin Pharmaceutical, Shanghai Shyndec Pharmaceutical, Henan Topfond Pharmaceutical, Novartis, Merck, LUNAN BETTER, Livzon Pharmaceutical and Wanbang Biopharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Statin market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Statin and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Statin revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Statin market size, projected growth trends, production technologies, key applications, and end-use industries.

Statin Segment by Company

CHIA TAI TIANQING

Zhejiang Jingxin Pharmaceutical

Shanghai Shyndec Pharmaceutical

Henan Topfond Pharmaceutical

Novartis

Merck

LUNAN BETTER

Livzon Pharmaceutical

Wanbang Biopharmaceuticals

Pfizer

Huizhi

China Resources Double-Crane Pharmaceutical

North China Pharmaceutical

Hanhui Pharmaceutical

Daiichi Sankyo

Beijing Jialin Pharmaceutical

AstraZeneca

Statin Segment by Type

Astrovastatin

Pitavastatin

Rosuvastatin

Others

Statin Segment by Application

Inflammatory Disorders

Cardiovascular Disorders

Obesity

Others

Statin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Statin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Statin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Statin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Statin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Statin industry.

Chapter 3: Detailed analysis of Statin companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Statinrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Statin Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Astrovastatin Table 3. Key Players of Pitavastatin Table 4. Key Players of Rosuvastatin Table 3. Key Players of Others Table 4. Global Statin Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Inflammatory Disorders Table 6. Key Players of Cardiovascular Disorders Table 7. Key Players of Obesity Table 8. Key Players of Others Table 9. Global Statin Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 10. Global Statin Market Size by Region (2021-2026) & (US$ Million) Table 11. Global Statin Market Share by Region (2021-2026) Table 12. Global Statin Market Size by Region (2027-2032) & (US$ Million) Table 13. Global Statin Market Share by Region (2027-2032) Table 14. Statin Industry Trends Table 15. Statin Industry Drivers Table 16. Statin Industry Opportunities and Challenges Table 17. Statin Industry Restraints Table 18. Global Statin Revenue by Company (US$ Million) & (2021-2026) Table 19. Global Statin Revenue Market Share by Company (2021-2026) Table 20. Global Statin Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 21. Global Statin Key Company Head Office and Area Served Table 22. Global Statin Company, Product Type & Application Table 23. Global Statin Company Establishment Date Table 24. Global Company Market Concentration Ratio (CR5 and HHI) Table 25. Global Statin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 26. Global Statin Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Statin Market Size by Type (2021-2026) & (US$ Million) Table 28. Global Statin Market Size by Type (2027-2032) & (US$ Million) Table 29. Global Statin Revenue Market Share by Type (2021-2026) Table 30. Global Statin Revenue Market Share by Type (2027-2032) Table 31. Global Statin Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global Statin Market Size by Application (2021-2026) & (US$ Million) Table 33. Global Statin Market Size by Application (2027-2032) & (US$ Million) Table 34. Global Statin Revenue Market Share by Application (2021-2026) Table 35. Global Statin Revenue Market Share by Application (2027-2032) Table 36. CHIA TAI TIANQING Company Information Table 37. CHIA TAI TIANQING Business Overview Table 38. CHIA TAI TIANQING Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. CHIA TAI TIANQING Statin Product Portfolio Table 40. CHIA TAI TIANQING Recent Development Table 41. Zhejiang Jingxin Pharmaceutical Company Information Table 42. Zhejiang Jingxin Pharmaceutical Business Overview Table 43. Zhejiang Jingxin Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Zhejiang Jingxin Pharmaceutical Statin Product Portfolio Table 45. Zhejiang Jingxin Pharmaceutical Recent Development Table 46. Shanghai Shyndec Pharmaceutical Company Information Table 47. Shanghai Shyndec Pharmaceutical Business Overview Table 48. Shanghai Shyndec Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Shanghai Shyndec Pharmaceutical Statin Product Portfolio Table 50. Shanghai Shyndec Pharmaceutical Recent Development Table 51. Henan Topfond Pharmaceutical Company Information Table 52. Henan Topfond Pharmaceutical Business Overview Table 53. Henan Topfond Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. Henan Topfond Pharmaceutical Statin Product Portfolio Table 55. Henan Topfond Pharmaceutical Recent Development Table 56. Novartis Company Information Table 57. Novartis Business Overview Table 58. Novartis Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. Novartis Statin Product Portfolio Table 60. Novartis Recent Development Table 61. Merck Company Information Table 62. Merck Business Overview Table 63. Merck Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Merck Statin Product Portfolio Table 65. Merck Recent Development Table 66. LUNAN BETTER Company Information Table 67. LUNAN BETTER Business Overview Table 68. LUNAN BETTER Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. LUNAN BETTER Statin Product Portfolio Table 70. LUNAN BETTER Recent Development Table 71. Livzon Pharmaceutical Company Information Table 72. Livzon Pharmaceutical Business Overview Table 73. Livzon Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Livzon Pharmaceutical Statin Product Portfolio Table 75. Livzon Pharmaceutical Recent Development Table 76. Wanbang Biopharmaceuticals Company Information Table 77. Wanbang Biopharmaceuticals Business Overview Table 78. Wanbang Biopharmaceuticals Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. Wanbang Biopharmaceuticals Statin Product Portfolio Table 80. Wanbang Biopharmaceuticals Recent Development Table 81. Pfizer Company Information Table 82. Pfizer Business Overview Table 83. Pfizer Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Pfizer Statin Product Portfolio Table 85. Pfizer Recent Development Table 86. Huizhi Company Information Table 87. Huizhi Business Overview Table 88. Huizhi Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 89. Huizhi Statin Product Portfolio Table 90. Huizhi Recent Development Table 91. China Resources Double-Crane Pharmaceutical Company Information Table 92. China Resources Double-Crane Pharmaceutical Business Overview Table 93. China Resources Double-Crane Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 94. China Resources Double-Crane Pharmaceutical Statin Product Portfolio Table 95. China Resources Double-Crane Pharmaceutical Recent Development Table 96. North China Pharmaceutical Company Information Table 97. North China Pharmaceutical Business Overview Table 98. North China Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 99. North China Pharmaceutical Statin Product Portfolio Table 100. North China Pharmaceutical Recent Development Table 101. Hanhui Pharmaceutical Company Information Table 102. Hanhui Pharmaceutical Business Overview Table 103. Hanhui Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 104. Hanhui Pharmaceutical Statin Product Portfolio Table 105. Hanhui Pharmaceutical Recent Development Table 106. Daiichi Sankyo Company Information Table 107. Daiichi Sankyo Business Overview Table 108. Daiichi Sankyo Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 109. Daiichi Sankyo Statin Product Portfolio Table 110. Daiichi Sankyo Recent Development Table 111. Beijing Jialin Pharmaceutical Company Information Table 112. Beijing Jialin Pharmaceutical Business Overview Table 113. Beijing Jialin Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 114. Beijing Jialin Pharmaceutical Statin Product Portfolio Table 115. Beijing Jialin Pharmaceutical Recent Development Table 116. AstraZeneca Company Information Table 117. AstraZeneca Business Overview Table 118. AstraZeneca Statin Revenue and Gross Margin (US$ Million) & (2021-2026) Table 119. AstraZeneca Statin Product Portfolio Table 120. AstraZeneca Recent Development Table 121. North America Statin Market Size by Type (2021-2026) & (US$ Million) Table 122. North America Statin Market Size by Type (2027-2032) & (US$ Million) Table 123. North America Statin Market Size by Application (2021-2026) & (US$ Million) Table 124. North America Statin Market Size by Application (2027-2032) & (US$ Million) Table 125. North America Statin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 126. North America Statin Market Size by Country (2021-2026) Table 127. North America Statin Market Size by Country (2027-2032) Table 128. Europe Statin Market Size by Type (2021-2026) & (US$ Million) Table 129. Europe Statin Market Size by Type (2027-2032) & (US$ Million) Table 130. Europe Statin Market Size by Application (2021-2026) & (US$ Million) Table 131. Europe Statin Market Size by Application (2027-2032) & (US$ Million) Table 132. Europe Statin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Statin Market Size by Country (2021-2026) Table 134. Europe Statin Market Size by Country (2027-2032) Table 135. China Statin Market Size by Type (2021-2026) & (US$ Million) Table 136. China Statin Market Size by Type (2027-2032) & (US$ Million) Table 137. China Statin Market Size by Application (2021-2026) & (US$ Million) Table 138. China Statin Market Size by Application (2027-2032) & (US$ Million) Table 139. Asia Statin Market Size by Type (2021-2026) & (US$ Million) Table 140. Asia Statin Market Size by Type (2027-2032) & (US$ Million) Table 141. Asia Statin Market Size by Application (2021-2026) & (US$ Million) Table 142. Asia Statin Market Size by Application (2027-2032) & (US$ Million) Table 143. Asia Statin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 144. Asia Statin Market Size by Country (2021-2026) Table 145. Asia Statin Market Size by Country (2027-2032) Table 146. South America, Middle East & Africa Statin Market Size by Type (2021-2026) & (US$ Million) Table 147. South America, Middle East & Africa Statin Market Size by Type (2027-2032) & (US$ Million) Table 148. South America, Middle East & Africa Statin Market Size by Application (2021-2026) & (US$ Million) Table 149. South America, Middle East & Africa Statin Market Size by Application (2027-2032) & (US$ Million) Table 150. South America, Middle East & Africa Statin Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 151. South America, Middle East & Africa Statin Market Size by Country (2021-2026) Table 152. South America, Middle East & Africa Statin Market Size by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Statin Product Image Figure 2. Global Statin Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Statin Market Share by Type: 2025 VS 2032 Figure 4. Astrovastatin Image Figure 5. Pitavastatin Image Figure 6. Rosuvastatin Image Figure 7. Others Image Figure 8. Global Statin Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global Statin Market Share by Application: 2025 VS 2032 Figure 10. Inflammatory Disorders Image Figure 11. Cardiovascular Disorders Image Figure 12. Obesity Image Figure 13. Others Image Figure 14. Global Statin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Statin Market Size (2021-2032) & (US$ Million) Figure 16. Global Statin Market Share by Region: 2025 VS 2032 Figure 17. Years Considered Figure 18. Global Statin Market Share by Players in 2025 Figure 19. Global Top 5 and 10 Statin Players Market Share by Revenue in 2025 Figure 20. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 21. Global Statin Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Statin Revenue Market Share by Type (2021-2032) Figure 23. Global Statin Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Statin Revenue Market Share by Application (2021-2032) Figure 25. North America Statin Market Size (2021-2032) & (US$ Million) Figure 26. North America Statin Market Share by Type (2021-2032) Figure 27. North America Statin Market Share by Application (2021-2032) Figure 28. North America Statin Market Share by Country (2021-2032) Figure 29. United States Statin Market Size (2021-2032) & (US$ Million) Figure 30. Canada Statin Market Size (2021-2032) & (US$ Million) Figure 31. Mexico Statin Market Size (2021-2032) & (US$ Million) Figure 32. Europe Statin Market Size (2021-2032) & (US$ Million) Figure 33. Europe Statin Market Share by Type (2021-2032) Figure 34. Europe Statin Market Share by Application (2021-2032) Figure 35. Europe Statin Market Share by Country (2021-2032) Figure 36. Germany Statin Market Size (2021-2032) & (US$ Million) Figure 37. France Statin Market Size (2021-2032) & (US$ Million) Figure 38. U.K. Statin Market Size (2021-2032) & (US$ Million) Figure 39. Italy Statin Market Size (2021-2032) & (US$ Million) Figure 40. Russia Statin Market Size (2021-2032) & (US$ Million) Figure 41. Nordic Countries Statin Market Size (2021-2032) & (US$ Million) Figure 42. China Statin Market Size (2021-2032) & (US$ Million) Figure 43. China Statin Market Share by Type (2021-2032) Figure 44. China Statin Market Share by Application (2021-2032) Figure 45. Asia Statin Market Size (2021-2032) & (US$ Million) Figure 46. Asia Statin Market Share by Type (2021-2032) Figure 47. Asia Statin Market Share by Application (2021-2032) Figure 48. Asia Statin Market Share by Country (2021-2032) Figure 49. Japan Statin Market Size (2021-2032) & (US$ Million) Figure 50. South Korea Statin Market Size (2021-2032) & (US$ Million) Figure 51. Taiwan Statin Market Size (2021-2032) & (US$ Million) Figure 52. Southeast Asia Statin Market Size (2021-2032) & (US$ Million) Figure 53. India Statin Market Size (2021-2032) & (US$ Million) Figure 54. Australia Statin Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa Statin Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa Statin Market Share by Type (2021-2032) Figure 57. South America, Middle East & Africa Statin Market Share by Application (2021-2032) Figure 58. South America, Middle East & Africa Statin Market Share by Country (2021-2032) Figure 59. Brazil Statin Market Size (2021-2032) & (US$ Million) Figure 60. South Africa Statin Market Size (2021-2032) & (US$ Million) Figure 61. Saudi Arabia Statin Market Size (2021-2032) & (US$ Million) Figure 62. Turkey Statin Market Size (2021-2032) & (US$ Million) Figure 63. Argentina Statin Market Size (2021-2032) & (US$ Million) Figure 64. UAE Statin Market Size (2021-2032) & (US$ Million) Figure 65. Egypt Statin Market Size (2021-2032) & (US$ Million) Figure 66. Chile Statin Market Size (2021-2032) & (US$ Million) Figure 67. Research Process Figure 68. Key Executives Interviewed

Scope & coverage.

Types
  • Astrovastatin
  • Pitavastatin
  • Rosuvastatin
  • Others
Applications
  • Inflammatory Disorders
  • Cardiovascular Disorders
  • Obesity
  • Others
Companies covered
  • CHIA TAI TIANQING
  • Zhejiang Jingxin Pharmaceutical
  • Shanghai Shyndec Pharmaceutical
  • Henan Topfond Pharmaceutical
  • Novartis
  • Merck
  • LUNAN BETTER
  • Livzon Pharmaceutical
  • Wanbang Biopharmaceuticals
  • Pfizer
  • Huizhi
  • China Resources Double-Crane Pharmaceutical
  • North China Pharmaceutical
  • Hanhui Pharmaceutical
  • Daiichi Sankyo
  • Beijing Jialin Pharmaceutical
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Statin Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Astrovastatin
  5. 1.2.3 Pitavastatin
  6. 1.2.4 Rosuvastatin
  7. 1.2.5 Others
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global Statin Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Inflammatory Disorders
  11. 1.3.3 Cardiovascular Disorders
  12. 1.3.4 Obesity
  13. 1.3.5 Others
  14. 1.4 Global Market Growth Prospects
  15. 1.5 Global Statin Growth Trends by Region
  16. 1.5.1 Global Statin Market Size by Region: 2021 VS 2025 VS 2032
  17. 1.5.2 Statin Market Size by Region (2021-2026)
  18. 1.5.3 Statin Market Size by Region (2027-2032)
  19. 1.6 Assumptions and Limitations
  20. 1.7 Study Goals and Objectives
  21. 1.8 Years Considered
2 Global Statin Market Dynamics
  1. 2.1 Statin Industry Trends
  2. 2.2 Statin Industry Drivers
  3. 2.3 Statin Industry Opportunities and Challenges
  4. 2.4 Statin Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Statin Revenue by Company (2021-2026)
  2. 3.2 Global Statin Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Statin Key Company Head office and Area Served
  4. 3.4 Global Statin Company, Product Type & Application
  5. 3.5 Global Statin Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Statin Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Statin Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Statin Tier 1, Tier 2, and Tier 3
4 Statin Market by Type
  1. 4.1 Global Statin Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Statin Market Size by Type (2021-2032)
  3. 4.3 Global Statin Market Size Share by Type (2021-2032)
5 Statin Market by Application
  1. 5.1 Global Statin Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Statin Market Size by Application (2021-2032)
  3. 5.3 Global Statin Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 CHIA TAI TIANQING
  2. 6.1.1 CHIA TAI TIANQING Company Information
  3. 6.1.2 CHIA TAI TIANQING Business Overview
  4. 6.1.3 CHIA TAI TIANQING Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 CHIA TAI TIANQING Statin Product Portfolio
  6. 6.1.5 CHIA TAI TIANQING Recent Developments
  7. 6.2 Zhejiang Jingxin Pharmaceutical
  8. 6.2.1 Zhejiang Jingxin Pharmaceutical Company Information
  9. 6.2.2 Zhejiang Jingxin Pharmaceutical Business Overview
  10. 6.2.3 Zhejiang Jingxin Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Zhejiang Jingxin Pharmaceutical Statin Product Portfolio
  12. 6.2.5 Zhejiang Jingxin Pharmaceutical Recent Developments
  13. 6.3 Shanghai Shyndec Pharmaceutical
  14. 6.3.1 Shanghai Shyndec Pharmaceutical Company Information
  15. 6.3.2 Shanghai Shyndec Pharmaceutical Business Overview
  16. 6.3.3 Shanghai Shyndec Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Shanghai Shyndec Pharmaceutical Statin Product Portfolio
  18. 6.3.5 Shanghai Shyndec Pharmaceutical Recent Developments
  19. 6.4 Henan Topfond Pharmaceutical
  20. 6.4.1 Henan Topfond Pharmaceutical Company Information
  21. 6.4.2 Henan Topfond Pharmaceutical Business Overview
  22. 6.4.3 Henan Topfond Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Henan Topfond Pharmaceutical Statin Product Portfolio
  24. 6.4.5 Henan Topfond Pharmaceutical Recent Developments
  25. 6.5 Novartis
  26. 6.5.1 Novartis Company Information
  27. 6.5.2 Novartis Business Overview
  28. 6.5.3 Novartis Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novartis Statin Product Portfolio
  30. 6.5.5 Novartis Recent Developments
  31. 6.6 Merck
  32. 6.6.1 Merck Company Information
  33. 6.6.2 Merck Business Overview
  34. 6.6.3 Merck Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Merck Statin Product Portfolio
  36. 6.6.5 Merck Recent Developments
  37. 6.7 LUNAN BETTER
  38. 6.7.1 LUNAN BETTER Company Information
  39. 6.7.2 LUNAN BETTER Business Overview
  40. 6.7.3 LUNAN BETTER Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 LUNAN BETTER Statin Product Portfolio
  42. 6.7.5 LUNAN BETTER Recent Developments
  43. 6.8 Livzon Pharmaceutical
  44. 6.8.1 Livzon Pharmaceutical Company Information
  45. 6.8.2 Livzon Pharmaceutical Business Overview
  46. 6.8.3 Livzon Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Livzon Pharmaceutical Statin Product Portfolio
  48. 6.8.5 Livzon Pharmaceutical Recent Developments
  49. 6.9 Wanbang Biopharmaceuticals
  50. 6.9.1 Wanbang Biopharmaceuticals Company Information
  51. 6.9.2 Wanbang Biopharmaceuticals Business Overview
  52. 6.9.3 Wanbang Biopharmaceuticals Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Wanbang Biopharmaceuticals Statin Product Portfolio
  54. 6.9.5 Wanbang Biopharmaceuticals Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Pfizer Statin Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 Huizhi
  62. 6.11.1 Huizhi Company Information
  63. 6.11.2 Huizhi Business Overview
  64. 6.11.3 Huizhi Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Huizhi Statin Product Portfolio
  66. 6.11.5 Huizhi Recent Developments
  67. 6.12 China Resources Double-Crane Pharmaceutical
  68. 6.12.1 China Resources Double-Crane Pharmaceutical Company Information
  69. 6.12.2 China Resources Double-Crane Pharmaceutical Business Overview
  70. 6.12.3 China Resources Double-Crane Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 China Resources Double-Crane Pharmaceutical Statin Product Portfolio
  72. 6.12.5 China Resources Double-Crane Pharmaceutical Recent Developments
  73. 6.13 North China Pharmaceutical
  74. 6.13.1 North China Pharmaceutical Company Information
  75. 6.13.2 North China Pharmaceutical Business Overview
  76. 6.13.3 North China Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 North China Pharmaceutical Statin Product Portfolio
  78. 6.13.5 North China Pharmaceutical Recent Developments
  79. 6.14 Hanhui Pharmaceutical
  80. 6.14.1 Hanhui Pharmaceutical Company Information
  81. 6.14.2 Hanhui Pharmaceutical Business Overview
  82. 6.14.3 Hanhui Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  83. 6.14.4 Hanhui Pharmaceutical Statin Product Portfolio
  84. 6.14.5 Hanhui Pharmaceutical Recent Developments
  85. 6.15 Daiichi Sankyo
  86. 6.15.1 Daiichi Sankyo Company Information
  87. 6.15.2 Daiichi Sankyo Business Overview
  88. 6.15.3 Daiichi Sankyo Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  89. 6.15.4 Daiichi Sankyo Statin Product Portfolio
  90. 6.15.5 Daiichi Sankyo Recent Developments
  91. 6.16 Beijing Jialin Pharmaceutical
  92. 6.16.1 Beijing Jialin Pharmaceutical Company Information
  93. 6.16.2 Beijing Jialin Pharmaceutical Business Overview
  94. 6.16.3 Beijing Jialin Pharmaceutical Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  95. 6.16.4 Beijing Jialin Pharmaceutical Statin Product Portfolio
  96. 6.16.5 Beijing Jialin Pharmaceutical Recent Developments
  97. 6.17 AstraZeneca
  98. 6.17.1 AstraZeneca Company Information
  99. 6.17.2 AstraZeneca Business Overview
  100. 6.17.3 AstraZeneca Statin Revenue and Gross Margin (US$ Million) & (2021-2026)
  101. 6.17.4 AstraZeneca Statin Product Portfolio
  102. 6.17.5 AstraZeneca Recent Developments
7 North America
  1. 7.1 North America Statin Market Size (2021-2032)
  2. 7.2 North America Statin Market Size by Type
  3. 7.2.1 North America Statin Market Size by Type (2021-2026)
  4. 7.2.2 North America Statin Market Size by Type (2027-2032)
  5. 7.2.3 North America Statin Market Share by Type (2021-2032)
  6. 7.3 North America Statin Market Size by Application
  7. 7.3.1 North America Statin Market Size by Application (2021-2026)
  8. 7.3.2 North America Statin Market Size by Application (2027-2032)
  9. 7.3.3 North America Statin Market Share by Application (2021-2032)
  10. 7.4 North America Statin Market Size by Country
  11. 7.4.1 North America Statin Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Statin Market Size by Country (2021-2026)
  13. 7.4.3 North America Statin Market Size by Country (2027-2032)
  14. 7.4.4 North America Statin Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Statin Market Size (2021-2032)
  2. 8.2 Europe Statin Market Size by Type
  3. 8.2.1 Europe Statin Market Size by Type (2021-2026)
  4. 8.2.2 Europe Statin Market Size by Type (2027-2032)
  5. 8.2.3 Europe Statin Market Share by Type (2021-2032)
  6. 8.3 Europe Statin Market Size by Application
  7. 8.3.1 Europe Statin Market Size by Application (2021-2026)
  8. 8.3.2 Europe Statin Market Size by Application (2027-2032)
  9. 8.3.3 Europe Statin Market Share by Application (2021-2032)
  10. 8.4 Europe Statin Market Size by Country
  11. 8.4.1 Europe Statin Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Statin Market Size by Country (2021-2026)
  13. 8.4.3 Europe Statin Market Size by Country (2027-2032)
  14. 8.4.4 Europe Statin Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Statin Market Size (2021-2032)
  2. 9.2 China Statin Market Size by Type
  3. 9.2.1 China Statin Market Size by Type (2021-2026)
  4. 9.2.2 China Statin Market Size by Type (2027-2032)
  5. 9.2.3 China Statin Market Share by Type (2021-2032)
  6. 9.3 China Statin Market Size by Application
  7. 9.3.1 China Statin Market Size by Application (2021-2026)
  8. 9.3.2 China Statin Market Size by Application (2027-2032)
  9. 9.3.3 China Statin Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Statin Market Size (2021-2032)
  2. 10.2 Asia Statin Market Size by Type
  3. 10.2.1 Asia Statin Market Size by Type (2021-2026)
  4. 10.2.2 Asia Statin Market Size by Type (2027-2032)
  5. 10.2.3 Asia Statin Market Share by Type (2021-2032)
  6. 10.3 Asia Statin Market Size by Application
  7. 10.3.1 Asia Statin Market Size by Application (2021-2026)
  8. 10.3.2 Asia Statin Market Size by Application (2027-2032)
  9. 10.3.3 Asia Statin Market Share by Application (2021-2032)
  10. 10.4 Asia Statin Market Size by Country
  11. 10.4.1 Asia Statin Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Statin Market Size by Country (2021-2026)
  13. 10.4.3 Asia Statin Market Size by Country (2027-2032)
  14. 10.4.4 Asia Statin Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Statin Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Statin Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Statin Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Statin Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Statin Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Statin Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Statin Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Statin Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Statin Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Statin Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Statin Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Statin Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Statin Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Statin Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst